Passion for Innovation. Compassion for Patients.™ Daiichi Sankyo Nordics ApS c/o

Passion for Innovation. Compassion for Patients.™

Daiichi Sankyo Nordics ApS c/o

Financial Transparency

Daiichi Sankyo is committed to bringing pharmaceutical innovation from bench to bedside. Innovation is paramount in all that we do, from pursuing new medicines and new methods of drug discovery and delivery, to achieving excellence throughout our organization.

Disclosure of Payments to Healthcare Professionals

A fruitful working relationship between the pharmaceutical industry and healthcare professionals has helped develop many life-saving medicines and has long been a positive driver for advancements in patient care and the progression of research.

EFPIA Disclosure Initiative

We fully support transparency and are prepared to disclose proper documentation of all our transfers of value, both to healthcare professionals (HCP) and healthcare organisations (HCO), under the EFPIA Disclosure Code and according country specific applicable laws and regulations.

Disclosure of Payments Report

Daiichi Sankyo Nordics TOV report 2020 Sweden

Daiichi Sankyo Nordics TOV report 2020 Norway

Daiich Sankyo Nordics TOV report 2020 Finland

Methodology Note 2020

Cooperation with Patient Associations

DS Nordics Report for Finland 2019

DS Nordics Report for Sweden 2019

DS Nordics Report for Norway 2019

DS Europe Report 2018